Which matters more for skin, DHA or EPA?

They complement each other. EPA is stronger for inflammation control. DHA contributes directly to skin barrier lipid structure. For inflammatory skin conditions (eczema, acne, rosacea), EPA-weighted products fit. For dryness and weakened barrier, DHA-weighted products are better.

Fish oil or algae-based omega-3?

Efficacy is comparable. Fish oil is more concentrated and cheaper but has fishy taste and mercury concerns. Algae-based omega-3 suits vegans and has lower contamination risk but costs more. Choose products with heavy-metal purity certifications (IFOS).

Do topical omega-3s work?

Yes. A 2026 systematic review confirmed topical DHA and EPA are safe and effective for skin. Oral intake lowers systemic inflammation; topical supports local barrier. Combining both is ideal for eczema management.

DHA 8 Weeks Significantly Lowers SCORAD in Atopic Dermatitis

Omega-3 fatty acids, specifically EPA and DHA, are accumulating clinical evidence for skin barrier function and inflammatory skin condition management. A 2024 trial in Nutrients (MDPI) reported that 8 weeks of oral DHA supplementation significantly reduced SCORAD scores in children with atopic dermatitis.

SCORAD and the Skin Barrier

SCORAD (Scoring Atopic Dermatitis) is the standard measure of eczema severity, combining lesion extent, intensity, and subjective symptoms (itch, sleep loss). A significant SCORAD drop from DHA supplementation means substantive clinical improvement, not just symptom ease.

Omega-3s act on two layers.

First, reducing transepidermal water loss (TEWL). Omega-3s support the stratum corneum’s lipid bilayer, slowing water escape through the skin. TEWL reduction is the most reliable indicator of stronger barrier function.

Second, inflammatory pathway modulation. EPA is converted through COX and LOX pathways into anti-inflammatory eicosanoids, addressing the chronic low-grade inflammation common to eczema, acne, psoriasis, and rosacea.

2026 Systematic Review Summary

The 2026 Journal of Integrative Dermatology systematic review reported that oral omega-3s show mixed efficacy across atopic dermatitis, acne, psoriasis, and rosacea. Evidence is strongest for eczema. Acne and rosacea still need larger trials.

Concurrently, a 2024 PMC review of topical DHA and EPA confirmed complementary effects to oral use in barrier improvement, itch relief, and dry skin management, with only mild irritation reported.

EPA vs DHA: Which Ratio

Inflammatory skin conditions (eczema, acne, rosacea): higher EPA products (EPA 1,000 mg : DHA 500 mg or higher)
Dryness and barrier weakness: higher DHA products (DHA 1,000 mg : EPA 500 mg or higher)
General health maintenance: EPA:DHA 2:1 or 1:1 balanced products

Clinical doses commonly run 1,000-2,000 mg combined EPA+DHA daily. Some eczema trials used DHA alone at 500-1,000 mg.

Fish Oil, Algae, and Krill Compared

Form	Pros	Cons
Fish oil	High concentration, affordable	Fishy taste, mercury concerns
Algae-derived	Vegan-friendly, lower contamination	Higher cost
Krill oil	Phospholipid form, high absorption	Very expensive

Quality certification matters. Products meeting IFOS (International Fish Oil Standards) or GOED standards carry lower heavy-metal and PCB contamination risk.

How to Take It

With meals: omega-3 is fat-soluble, so fat-containing meals maximize absorption
Prevent oxidation: refrigerate after opening. Strong fishy smell means oxidation; replace
Anticoagulant caution: consult clinician if on warfarin or aspirin

Omega-3 is internal skin infrastructure. If serums and creams manage the surface, omega-3 supplies the raw material of the barrier itself through diet. For recurring eczema, acne, or dryness, oral omega-3 for 8+ weeks with tracking of TEWL, SCORAD, or daily symptom changes is a reasonable approach.

Source: MDPI Nutrients / PMC